Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2006 2
2008 2
2009 1
2012 1
2013 1
2014 3
2015 2
2016 3
2018 3
2019 2
2020 1
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, Damasceno A, Avezum A, Dans AML, Gitura B, Hu D, Kamanzi ER, Maklady F, Fana G, Gonzalez-Hermosillo JA, Musuku J, Kazmi K, Zühlke L, Gondwe L, Ma C, Paniagua M, Ogah OS, Molefe-Baikai OJ, Lwabi P, Chillo P, Sharma SK, Cabral TTJ, Tarhuni WM, Benz A, van Eikels M, Krol A, Pattath D, Balasubramanian K, Rangarajan S, Ramasundarahettige C, Mayosi B, Yusuf S; INVICTUS Investigators. Connolly SJ, et al. N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036525 Clinical Trial.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, Kango M, Abul-Fadl A, Adeoye A, Ali S, Al-Kebsi M, Bode-Thomas F, Bukhman G, Damasceno A, Goshu DY, Elghamrawy A, Gitura B, Haileamlak A, Hailu A, Hugo-Hamman C, Justus S, Karthikeyan G, Kennedy N, Lwabi P, Mamo Y, Mntla P, Sutton C, Mocumbi AO, Mondo C, Mtaja A, Musuku J, Mucumbitsi J, Murango L, Nel G, Ogendo S, Ogola E, Ojji D, Olunuga TO, Redi MM, Rusingiza KE, Sani M, Sheta S, Shongwe S, van Dam J, Gamra H, Carapetis J, Lennon D, Mayosi BM. Watkins D, et al. Among authors: mntla p. Cardiovasc J Afr. 2016 May/Jun 23;27(3):184-187. doi: 10.5830/CVJA-2015-090. Epub 2016 Jan 12. Cardiovasc J Afr. 2016. PMID: 26815006 Free PMC article.
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.
Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Chitsa Banda A, Brown B, Manga P, Kirenga B, Mondo C, Mntla P, Tsitsi JM, Peters F, Essop MR, Russell JB, Hakim J, Matenga J, Barasa AF, Sani MU, Olunuga T, Ogah O, Ansa V, Aje A, Danbauchi S, Ojji D, Yusuf S; IMPI Trial Investigators. Mayosi BM, et al. Among authors: mntla p. N Engl J Med. 2014 Sep 18;371(12):1121-30. doi: 10.1056/NEJMoa1407380. Epub 2014 Sep 1. N Engl J Med. 2014. PMID: 25178809 Free PMC article. Clinical Trial.
Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
Karthikeyan G, Devasenapathy N, Zühlke L, Engel ME, Rangarajan S, Teo KK, Mayosi BM, Yusuf S; Global Rheumatic Heart Disease Registry (REMEDY) Investigators. Karthikeyan G, et al. Heart. 2019 Mar;105(5):363-369. doi: 10.1136/heartjnl-2018-313614. Epub 2018 Sep 12. Heart. 2019. PMID: 30209123
Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.
Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, Kramer N, Barasa F, Damasceno A, Dzudie A, Jones E, Mondo C, Ogah O, Ogola E, Sani MU, Shedul GL, Shedul G, Rayner B, Okpechi IG, Sliwa K, Poulter N; CREOLE Study Investigators. Ojji DB, et al. N Engl J Med. 2019 Jun 20;380(25):2429-2439. doi: 10.1056/NEJMoa1901113. Epub 2019 Mar 18. N Engl J Med. 2019. PMID: 30883050 Free article. Clinical Trial.
Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action.
Mayosi BM, Gamra H, Dangou JM, Kasonde J; 2nd All-Africa Workshop on Rheumatic Fever and Rheumatic Heart Disease participants. Mayosi BM, et al. Lancet Glob Health. 2014 Aug;2(8):e438-9. doi: 10.1016/S2214-109X(14)70234-7. Epub 2014 Jul 23. Lancet Glob Health. 2014. PMID: 25103507 Free article. No abstract available.
Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm.
Ndadza A, Muyambo S, Mntla P, Wonkam A, Chimusa E, Kengne AP, Ntsekhe M, Dandara C. Ndadza A, et al. Among authors: mntla p. J Thromb Haemost. 2021 Dec;19(12):2957-2973. doi: 10.1111/jth.15494. Epub 2021 Sep 29. J Thromb Haemost. 2021. PMID: 34382722 Free PMC article.
24 results